Early research (Phase 1)Ended earlyNCT01929941
What this trial is testing
An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies
Who this might be right for
Solid TumorHodgkin's LymphomaNHL (Non-Hodgkin Lymphoma)+5 more
Incyte Corporation 5